MDM2 and cancer: It has also been found that HBX 19,818 inhibits cancer cell viability in a p53-independent manner, which emphasizes the critical role of the p53-independent functions of MDM2 and MDMX in cancer cells (Qin et al., 2018; Wang et al., 2019b).